Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 10

Effect of diabetes mellitus on prognosis and development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

Pages
2272–2276
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no significant difference between the DM and non-DM groups according to bothoverall survival (p=0.115) and time of HCC development (p=0.567).Conclusion: While HCC development and overall survival were similar in both groups, in the subgroup of patients who did not developHCC, the annual increase in CHILD score and final CHILD score were significantly higher in DM patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Hepatitis C virus (HCV) infection and diabetes mellitus (DM) negatively affect each other.
📊
Key Findings & Data:In this study, we aimed to investigate the effect of DM on complicationrate, hepatocellular cancer (HCC) development and mortality in HCV RNA (+) cirrhosis patients.Material and Methods: Patients admitted with Hepatitis C-related cirrhosis and followed up for at İzmir Katip Çelebi UniversityAtatürk Training and Research Hospital Gastroenterology and Internal Medicine Clinic for at least six months between 2005and 2014were retrospectively evaluated.Results: A total of 146 patients with HCV-related cirrhosis were included in the study.
💡
Conclusion & Impact:There was no significant difference between the DM and non-DM groups according to bothoverall survival (p=0.115) and time of HCC development (p=0.567).Conclusion: While HCC development and overall survival were similar in both groups, in the subgroup of patients who did not developHCC, the annual increase in CHILD score and final CHILD score were significantly higher in DM patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Hepatitis C virus (HCV) infection and diabetes mellitus (DM) negatively affect each other. HCV patients diagnosed with DM havemore complications than patients with HCV infection alone. In this study, we aimed to investigate the effect of DM on complicationrate, hepatocellular cancer (HCC) development and mortality in HCV RNA (+) cirrhosis patients.Material and Methods: Patients admitted with Hepatitis C-related cirrhosis and followed up for at İzmir Katip Çelebi UniversityAtatürk Training and Research Hospital Gastroenterology and Internal Medicine Clinic for at least six months between 2005and 2014were retrospectively evaluated.Results: A total of 146 patients with HCV-related cirrhosis were included in the study. Of these patients, 53 (36.3%) had diagnosisof DM. In 108 patients who did not develop hepatocellular carcinoma (HCC), the mean CHILD score at final admission (p=0.024),difference between mean CHILD scores at final and initial admission (p=0.011), and annual rate of increase in CHILD score (p=0.047)was significantly higher in the DM group. There was no significant difference between the DM and non-DM groups according to bothoverall survival (p=0.115) and time of HCC development (p=0.567).Conclusion: While HCC development and overall survival were similar in both groups, in the subgroup of patients who did not developHCC, the annual increase in CHILD score and final CHILD score were significantly higher in DM patients.

🔖

Cite This Article

VATANSEVER, S., TAŞKAYNATAN, H., AKTAŞ, G. (2022). Effect of diabetes mellitus on prognosis and development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Annals of Medical Research, Cilt: 26 - Sayı: 10, 2272–2276. https://ajindex.com/articles/446997

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Davis GL, Albright JE, Cook SF. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:3318
  2. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat 1999;6:3547
  3. WHO. Hepatitis C: Fact sheet N°164
  4. Serfaty L. Metabolic Manifestations of hepatitis c virus: diabetes mellitus, dyslipidemia. Clin Liver Dis 2017;21:475-86
  5. Noto H, Raskin P. Hepatitis C infection and diabetes. J Diabetes Complications 2006;20:113-20
  6. Elkrief L, Rautou PE, Sarin S. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int 2016;36:936-48. 7. de Marco R, Locatelli F, Zoppini G. Cause-specific mortality in type 2 diabetes. The Verona diabetes study. Diabetes Care 1999;22:756–61
  7. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460–8
  8. Zoppini G, Fedeli U, Gennaro N. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol 2014;109:1020–5
  9. Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 2015;61:1066–79
  10. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98– 107
  11. Petta S, Camma C, Marco VD, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 2008;103:1136–44
  12. Ghany MG, Kleiner DE, Alter H, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003;124:97–104
  13. Stanley S. Schwartz, Struan FA. et al. Intersections and clinical translations of diabetes mellitus with cancer promotion, progression and prognosis, Postgraduate Medicine. Accepted article: August 15, 2019. Published online: Sep 5,2019
  14. Dyal HK, Aguilar M, Bartos G, et al. Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic review. Dig Dis Sci 2016;61:636-45
  15. Desbois AC, Cacoub P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. 2017;23:1697-711
  16. Perz JF, Armstrong GL, Farrington LA. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529–38
  17. Wang YG, Wang P, Wang B. Diabetes mellitus and p